Non-comparative Study to Assess the Visual Performances and Safety of a Progressive Multifocal Intraocular Lens (PSM15)

January 13, 2020 updated by: SIFI SpA

An Open Label, Non-comparative Study to Assess the Visual Performances and Safety of a Progressive Multifocal Intraocular Lens With Extended Depth of Focus

This is an interventional, non-controlled, multicenter international trial with a prospective design on one cohort of patients.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

To evaluate if the positive results (to assure a good visual acuity at all distances and a good quality of life in terms of glasses independence and absence of undesired events), obtained experimentally using the IOL MINI WELL READY, can be confirmed in the practical surgical routine with a population belonging to different EU countries

Study Type

Interventional

Enrollment (Actual)

77

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Heidelberg, Germany
        • Prof.Dr. Gerd U. Auffarth

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Any gender and age above 18 years.
  • Refractive lens exchange (RLE) or cataract surgery.
  • Healthy corneas, not treated surgically.
  • Patients willing to have surgery in both eyes in a short period of time (within 2 weeks).
  • Patients request to receive the IOL MINI WELL READY implant

Exclusion Criteria:

  • Previous corneal surgery (i.e. pterygium, refractive surgery).
  • Eye diseases determining a probable postoperative visual acuity < 20/40.
  • Pseudoexfoliation.
  • Abnormal pupil size and position.
  • Use of contact lens 30 days before the preoperative visit.
  • Corneal warpage.
  • Predicted postoperative corneal astigmatism higher than 1 D.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Single arm receiving Mini WELL Ready IOL
IOL implantation for cataract
IOL MINI WELL READY

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
UDVA (Uncorrected Distance Visual Acuity)
Time Frame: 30 days
Visual acuity mesurement
30 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adverse Device Effects (ADE); Serious Adverse Device Effects (SADE); Unexpected Serious Adverse Device Effects (USADE); Adverse Events (AE); Serious Adverse Events (SAE).
Time Frame: 4 months
Safety assessment
4 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Acuity Evaluation
Time Frame: 4 months
Corrected Distance Visual Acuity (CDVA)
4 months
Visual Acuity Evaluation
Time Frame: 4 months
Uncorrected Near Visual Acuity (UNVA)
4 months
Visual Acuity Evaluation
Time Frame: 4 months
Distance-Corrected Near Visual Acuity (DCNVA)
4 months
Visual Acuity Evaluation
Time Frame: 4 months
Corrected Near Visual Acuity (CNVA)
4 months
Visual Acuity Evaluation
Time Frame: 4 months
Uncorrected Intermediate Visual Acuity (UIVA)
4 months
Visual Acuity Evaluation
Time Frame: 4 months
Distance-Corrected Intermediate Visual Acuity (DCIVA)
4 months
Halos and Glare evaluation
Time Frame: 4 months
Onset of halos Onset of glare during night vision
4 months
Contrast sensitivity
Time Frame: 4 months
Contrast sensitivity, at 3 meters, under photopic conditions and with the correction for distance, using YANG SMART (SIFI Medtech), with sine wave gradings (''vistech")
4 months
Reading Performance
Time Frame: 4 months

Reading Performance tested with Radner Reading Chart - Precision Vision:

The test will be performed from the largest to the smallest size of letters in two sessions:

  • Binocular, without the correction for distance, at 40 cm
  • Binocular, with the correction for distance, at 40 cm
4 months
Defocus Curve
Time Frame: 4 months
Binocular defocus curves with step of 0.5 D (from +2.0 to -5.0 D) under photopic conditions.
4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: GERD U. AUFFARTH, Prof. Dr., RUPRECHT KARLS UNIVERSITATS AUGENKLINIK HEIDELBERG

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2016

Primary Completion (Actual)

October 1, 2017

Study Completion (Actual)

October 1, 2017

Study Registration Dates

First Submitted

July 12, 2016

First Submitted That Met QC Criteria

July 15, 2016

First Posted (Estimate)

July 20, 2016

Study Record Updates

Last Update Posted (Actual)

January 14, 2020

Last Update Submitted That Met QC Criteria

January 13, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • PSM15

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cataract

Clinical Trials on IOL MINI WELL READY

3
Subscribe